|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
5
|
|
gptkbp:bfsParent
|
gptkb:Benadryl
|
|
gptkbp:activities
|
H1 receptor antagonist
|
|
gptkbp:approves
|
gptkb:1956
|
|
gptkbp:brand
|
Atarax
Vistaril
|
|
gptkbp:category
|
Category C
|
|
gptkbp:clinical_trial
|
Phase IV
|
|
gptkbp:composed_of
|
synthetic
|
|
gptkbp:contraindication
|
gptkb:asthma
gptkb:sneaker
severe respiratory depression
allergy to hydroxyzine
|
|
gptkbp:dosage_form
|
100 mg
50 mg
25 mg
10 mg/ml
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:formulation
|
gptkb:product
gptkb:tablet
injection
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
hydroxyzine
|
|
gptkbp:ingredients
|
C21 H27 Cl N2 O2
|
|
gptkbp:interacts_with
|
gptkb:beer
CNS depressants
MAO inhibitors
opioids
|
|
gptkbp:is_atype_of
|
N05 B A01
|
|
gptkbp:is_used_for
|
anxiety
nausea
allergic reactions
insomnia
|
|
gptkbp:legal_issue
|
Prescription only
|
|
gptkbp:manager
|
oral
intramuscular
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:related_to
|
gptkb:chlorpheniramine
gptkb:diphenhydramine
gptkb:promethazine
cetirizine
fexofenadine
|
|
gptkbp:side_effect
|
dizziness
drowsiness
constipation
dry mouth
blurred vision
|
|
gptkbp:type_of
|
50-53-3
|
|
gptkbp:year_created
|
1950s
|